Showing 1 to 7 of 7 results
FDA Director Prasad Resigns, Then Returns Amidst Controversy
Vinay Prasad, the FDA's Center for Biologics Evaluation and Research director, resigned on July 30th following criticism of the agency's handling of a gene therapy linked to patient deaths and attacks from Laura Loomer, but returned to his position on August 10th at the FDA's request.
FDA Director Prasad Resigns, Then Returns Amidst Controversy
Vinay Prasad, the FDA's Center for Biologics Evaluation and Research director, resigned on July 30th following criticism of the agency's handling of a gene therapy linked to patient deaths and attacks from Laura Loomer, but returned to his position on August 10th at the FDA's request.
Progress
40% Bias Score
FDA Official Returns After Resignation Amid Political Pressure
Dr. Vinay Prasad, FDA's Center for Biologics Evaluation and Research director, resigned in late July under White House pressure and attacks from Laura Loomer, but returned to his position on Saturday, prompting further criticism and threats of continued exposure from Loomer.
FDA Official Returns After Resignation Amid Political Pressure
Dr. Vinay Prasad, FDA's Center for Biologics Evaluation and Research director, resigned in late July under White House pressure and attacks from Laura Loomer, but returned to his position on Saturday, prompting further criticism and threats of continued exposure from Loomer.
Progress
56% Bias Score
FDA Official Resigns Amidst Political Pressure
Dr. Vinay Prasad, the FDA's head of the Center for Biologics Evaluation and Research, resigned after less than three months due to White House pressure and public criticism from right-wing activist Laura Loomer, who accused him of being a "progressive leftist saboteur".
FDA Official Resigns Amidst Political Pressure
Dr. Vinay Prasad, the FDA's head of the Center for Biologics Evaluation and Research, resigned after less than three months due to White House pressure and public criticism from right-wing activist Laura Loomer, who accused him of being a "progressive leftist saboteur".
Progress
60% Bias Score
FDA Appoints Vaccine Critic to Oversee Drug Program
Dr. Vinay Prasad, a critic of the FDA and COVID-19 measures, has been appointed to lead the agency's vaccine and biotech drug program, replacing Dr. Peter Marks who resigned after clashes with Robert F. Kennedy Jr. over vaccine safety. Prasad's appointment raises concerns about potential increased s...
FDA Appoints Vaccine Critic to Oversee Drug Program
Dr. Vinay Prasad, a critic of the FDA and COVID-19 measures, has been appointed to lead the agency's vaccine and biotech drug program, replacing Dr. Peter Marks who resigned after clashes with Robert F. Kennedy Jr. over vaccine safety. Prasad's appointment raises concerns about potential increased s...
Progress
52% Bias Score
FDA's Prasad Resumes Role After Resignation Amid Political Pressure
Dr. Vinay Prasad, the FDA's chief medical and scientific officer, resigned in late July amid White House pressure and criticism from Laura Loomer but has since returned to his position at the agency's request.
FDA's Prasad Resumes Role After Resignation Amid Political Pressure
Dr. Vinay Prasad, the FDA's chief medical and scientific officer, resigned in late July amid White House pressure and criticism from Laura Loomer but has since returned to his position at the agency's request.
Progress
56% Bias Score
FDA Chief Medical Officer Resigns Amidst Political Pressure
Dr. Vinay Prasad, the FDA's chief medical and scientific officer, resigned after less than three months due to White House pressure and public criticism from right-wing activist Laura Loomer, following a recent FDA reversal on Sarepta's Elevidys drug shipments.
FDA Chief Medical Officer Resigns Amidst Political Pressure
Dr. Vinay Prasad, the FDA's chief medical and scientific officer, resigned after less than three months due to White House pressure and public criticism from right-wing activist Laura Loomer, following a recent FDA reversal on Sarepta's Elevidys drug shipments.
Progress
44% Bias Score
FDA Appoints Covid-19 Vaccine Critic to Lead Biologics Division
The FDA appointed Dr. Vinay Prasad, a vocal critic of its Covid-19 policies, to head its Center for Biologics Evaluation and Research, replacing Dr. Peter Marks who resigned after criticizing HHS Secretary Robert F. Kennedy Jr. This appointment caused a 5% drop in biotech stocks and prompted concern...
FDA Appoints Covid-19 Vaccine Critic to Lead Biologics Division
The FDA appointed Dr. Vinay Prasad, a vocal critic of its Covid-19 policies, to head its Center for Biologics Evaluation and Research, replacing Dr. Peter Marks who resigned after criticizing HHS Secretary Robert F. Kennedy Jr. This appointment caused a 5% drop in biotech stocks and prompted concern...
Progress
48% Bias Score
Showing 1 to 7 of 7 results